Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel

被引：0
|
作者：
Garcia, Annie [1 ]
Reuther, Jacquelyn [2 ]
Voicu, Horatiu [2 ]
Mohila, Carrie [3 ]
Adesina, Adekunle [2 ]
Schady, Deborah [3 ]
Wang, Wei-Lien Billy [4 ]
Lazar, Alexander [4 ]
Lopez-Terrada, Dolores [2 ]
Lin, Frank [2 ]
Venkatramani, Rajkumar [2 ]
Plon, Sharon [2 ]
Parsons, Williams [2 ]
Fisher, Kevin [2 ]
Roy, Angshumoy [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
39
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [1] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 36 - 37
  • [2] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 817 - 818
  • [3] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 817 - 818
  • [4] Clinical and analytic validation of FoundationOne CDx™ for NTRK fusion-positive solid tumors in patients treated with entrectinib
    Fabrizio, David
    Milbury, Coren
    Yip, Wai-Ki
    Yilmazel, Bahar
    Bai, Xiaobo
    Liao, Juan
    Smith, David
    Burns, Christine
    Vietz, Christine
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [5] Challenges in the Diagnosis of NTRK Fusion-Positive Cancers
    Gautschi, Oliver
    Bubendorf, Lukas
    Leyvraz, Serge
    Menon, Roopika
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E107 - E109
  • [6] Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours
    Lassen, Ulrik
    LANCET ONCOLOGY, 2020, 21 (02): : 193 - 194
  • [7] Progression free survival of larotrectinib in patients with NTRK fusion-positive tumors: a systematic review
    Sumampow, M. M. A.
    Fu, R. C. E.
    Delvino, D.
    Albert, N.
    Danisha, P. A. C.
    Satcitta, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1353 - S1353
  • [8] Challenges in the Diagnosis of NTRK Fusion-Positive Cancers Response
    Jett, James R.
    Kim, Edward S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E109 - E110
  • [9] NTRK fusion-positive cancers and TRK inhibitor therapy
    Cocco, Emiliano
    Scaltriti, Maurizio
    Drilon, Alexander
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 731 - 747
  • [10] NTRK fusion-positive colorectal cancer in Japanese population
    Yonemaru, Junpei
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Naka, Tomoaki
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Shiraishi, Kouya
    Sekine, Shigeki
    PATHOLOGY INTERNATIONAL, 2021, 71 (05) : 355 - 359
12345